Bacteroidetes/Firmicutes ratio

The Bacteroidetes/Firmicutes ratio was prominently proposed in the mid-2000s as a functional biomarker of gut microbiome health, based on observations in obese mice and small human cohorts that obesity was associated with a relative reduction in Bacteroidetes and expansion of Firmicutes, and that weight loss reversed this pattern. The mechanistic hypothesis was that a high-Firmicutes microbiome extracts more energy from the same diet, thus promoting fat accumulation. However, this simplified narrative has not replicated reliably across diverse human cohorts: large subsequent studies found the ratio to vary substantially with sequencing methodology, diet, geography and cohort composition, and many found no consistent direction of association with obesity or metabolic health. The field has largely deprioritised this ratio as a clinically meaningful metric, recognising that the division of the gut microbiota into two phyla discards the vast functional diversity within each, and that species- or gene-level analyses provide much more informative resolution. It persists in popular science writing and supplement marketing, where it is frequently overstated.